http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Using patient friendly composite endpoints to measure the success of acute migraine medications
proceedings from the 4th Annual Migraine Meeting, Budapest, Hungary, October 15-17, 2004
Annual Migraine Meeting 2004 : Budapest, Hungary)
Introduction / J. Pascual -- What do patients want from their acute migraine therapy / M. Lantéri-Minet -- Migraine, allodynia, sensitisation and all of that ... / P.J. Goadsby -- Should we advise patients to treat migraine attacks early : methodologic issues / M.D. Ferrai -- Defining response in migraine : which endpoints are important? / J. Edmeads -- Efficacy and tolerability of almotriptan in controlled clinical trials / N.T. Matthew -- Efficacy and tolerability of almotriptan in postmarketing surveillance studies / J. Pascual -- Almotriptan in migraine patients who respond poorly to oral sumatriptan : a double-blind, randomized trial / H.-C Diener, A. Gendolla, L. Gebert, M. Beneke.
Title from ebook title screen (viewed July 8, 2005)
Published as part of European Neurology, volume 53, Suppl. 1, 2005.
Made available through NetLibrary; access may be limited to NetLibrary affiliated libraries.